Provided by Tiger Fintech (Singapore) Pte. Ltd.

Summit Therapeutics PLC

29.13
-0.1900-0.65%
Post-market: 29.01-0.1217-0.42%19:56 EDT
Volume:3.90M
Turnover:115.25M
Market Cap:21.63B
PE:-85.79
High:30.98
Open:29.05
Low:28.61
Close:29.32
Loading ...

Summit Therapeutics Gets Approval From China's Health Authority for Second Use of Ivonescimab

MT Newswires Live
·
26 Apr

Summit Therapeutics trading resumes

TIPRANKS
·
26 Apr

Summit Therapeutics to resume trading at 3:20 pm ET

TIPRANKS
·
26 Apr

Summit Therapeutics says new ivonescimab data clinically meaningful

TIPRANKS
·
26 Apr

Wells says Summit, Akeso data ‘not the bull case,’ but not ‘bear case either’

TIPRANKS
·
26 Apr

Summit Therapeutics trading halted, news pending

TIPRANKS
·
26 Apr

Summit Therapeutics to Host First Quarter 2025 Financial Results & Operational Progress Call on May 1, 2025

Business Wire
·
25 Apr

Evercore ISI Remains a Buy on Summit Therapeutics (SMMT)

TIPRANKS
·
24 Apr

Why Summit Therapeutics Inc. (SMMT) Went Up On Wednesday

Insider Monkey
·
24 Apr

Summit Therapeutics Says Phase 3 Cell Lung Cancer Trial Met Primary Endpoint; Shares Rise Pre-Bell

MT Newswires Live
·
23 Apr

BUZZ-Summit Therapeutics gains as lung cancer drug succeeds in second study in China

Reuters
·
23 Apr

S&P 500 Futures Rise In Premarket Trading; Pegasystems, Popular Inc. Lead

Dow Jones
·
23 Apr

Summit Therapeutics Rallies After Lung Cancer Drug Shows Positive Results

Dow Jones
·
23 Apr

Ivonescimab in Combination with Chemotherapy Achieves Statistically Significant Superiority in PFS vs. Tislelizumab (PD-1 Inhibitor) Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in HARMONi-6 Study Conducted by Akeso in China

Business Wire
·
23 Apr

Top Stock Reports for Netflix, SAP & Shell

Zacks
·
17 Apr

Why Summit Therapeutics Inc. (SMMT) Skyrocketed On Monday?

Insider Monkey
·
15 Apr

Summit Therapeutics (NasdaqGM:SMMT) Welcomes Robert LaCaze As New Chief Commercial Officer

Simply Wall St.
·
15 Apr

Here's Why Summit Therapeutics Stock Soared 15% on Friday

Zacks
·
14 Apr

Why Summit Therapeutics Inc. (SMMT) Went Up On Thursday?

Insider Monkey
·
11 Apr

Summit co-CEO option exercise ‘quite bullish,’ says Cantor Fitzgerald

TIPRANKS
·
11 Apr